Advertisement

Topics

Aerie Pharmaceuticals Enters into Collaboration Agreement with DSM Focused on Technology to ...

02:06 EDT 31 Jul 2017 | BioMedReports - Blog
Aerie Pharmaceuticals
Richard Rubino, 908-947-3540
rrubino@aeriepharma.com
or
Burns McClellan, Inc., on behalf of Aerie Pharmaceuticals
Investors
Ami Bavishi, 212-213-0006
abavishi@burnsmc.com
or
Media
Justin Jackson, 212-213-0006
jjackson@burnsmc.com

Read more...

Original Article: Aerie Pharmaceuticals Enters into Collaboration Agreement with DSM Focused on Technology to ...

NEXT ARTICLE

More From BioPortfolio on "Aerie Pharmaceuticals Enters into Collaboration Agreement with DSM Focused on Technology to ..."

Quick Search
Advertisement